| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $328.75 | $929.95 | $398.56 | |
| Short term investments | ||||
| Net receivables | $1441.81 | $1559.91 | $1519.46 | $1432.04 |
| Inventory | $1214.27 | $1238.81 | $1245.66 | $1225.45 |
| Total current assets | $3745.9 | $3265.97 | $3909.94 | $3390.24 |
| Long term investments | ||||
| Property, plant & equipment | $995.77 | $1025.44 | $1024.34 | $1031.82 |
| Goodwill & intangible assets | $6432.82 | $6484.88 | $6365.6 | |
| Total noncurrent assets | $8025.79 | $8077.09 | $7958.28 | |
| Total investments | ||||
| Total assets | $11912.97 | $11291.76 | $11987.03 | $11348.51 |
| Current liabilities | ||||
| Accounts payable | $865.19 | $974.32 | $969.76 | $1880.92 |
| Deferred revenue | $230.43 | $242.06 | $211.29 | |
| Short long term debt | $210.47 | $968.97 | $468.28 | |
| Total current liabilities | $2387.2 | $2134.16 | $2984.43 | $2413.77 |
| Long term debt | $3007.82 | $2960.91 | $2973.49 | $2991.76 |
| Total noncurrent liabilities | $3793.98 | $3849.75 | $3828.14 | |
| Total debt | $3171.39 | $3942.46 | $3460.04 | |
| Total liabilities | $6214.97 | $5928.14 | $6834.18 | $6241.91 |
| Shareholders' equity | ||||
| Retained earnings | $12044.4 | $11768.02 | $11556.41 | $10995.62 |
| Other shareholder equity | -$213.24 | -$266.77 | -$254.4 | $5106.6 |
| Total shareholder equity | $5363.62 | $5152.85 | $5106.6 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $398.56 | $380.87 | $385.5 | $513.08 |
| Short term investments | ||||
| Net receivables | $1432.04 | $1516.87 | $1347.51 | $1137.22 |
| Inventory | $1225.45 | $1366.61 | $1191.1 | $835.8 |
| Total current assets | $3390.24 | $3423.47 | $3061.71 | $2619.19 |
| Long term investments | ||||
| Property, plant & equipment | $1031.82 | $1004.83 | $957.31 | $897.33 |
| Goodwill & intangible assets | $6365.6 | $6003.23 | $5918.34 | $5156.31 |
| Total noncurrent assets | $7958.28 | $7473.05 | $7341.92 | $6532.89 |
| Total investments | ||||
| Total assets | $11348.51 | $10896.52 | $10403.63 | $9152.07 |
| Current liabilities | ||||
| Accounts payable | $1880.92 | $2037.5 | $1073.57 | $853.94 |
| Deferred revenue | $211.29 | $256.93 | $227.55 | $184.84 |
| Short long term debt | $468.28 | $735.77 | $105.7 | |
| Total current liabilities | $2413.77 | $2773.27 | $2250.34 | $1738.8 |
| Long term debt | $2991.76 | $2942.51 | $3018.71 | $3108.83 |
| Total noncurrent liabilities | $3828.14 | $3836.88 | $3963.76 | $4027.5 |
| Total debt | $3460.04 | $3678.28 | $3124.42 | $3108.83 |
| Total liabilities | $6241.91 | $6610.15 | $6214.1 | $5766.3 |
| Shareholders' equity | ||||
| Retained earnings | $10995.62 | $10223.07 | $9445.25 | $8608.28 |
| Other shareholder equity | $5106.6 | $4286.37 | -$154.05 | -$153.25 |
| Total shareholder equity | $5106.6 | $4286.37 | $4189.53 | $3385.77 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1983.54 | $2178.26 | $2093.94 | $2105.76 |
| Cost of revenue | $1356.69 | $1336.69 | ||
| Gross Profit | $770.96 | $821.57 | $757.25 | $785.76 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $452.19 | $463.12 | ||
| Total operating expenses | $423.5 | $452.19 | $463.12 | $431.29 |
| Operating income | $369.37 | $294.13 | ||
| Income from continuing operations | ||||
| EBIT | $385.66 | $835.25 | ||
| Income tax expense | $73.43 | $71.47 | $166.66 | $32.97 |
| Interest expense | -$28.95 | $32.37 | $36.37 | -$25.95 |
| Net income | ||||
| Net income | $347.1 | $281.82 | $632.22 | $296.26 |
| Income (for common shares) | $281.82 | $632.22 | ||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $8438.13 | $8508.09 | $7907.08 | $6683.76 |
| Cost of revenue | $5444.53 | $4937.3 | $4209.74 | |
| Gross Profit | $3084.63 | $3063.56 | $2969.79 | $2474.02 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1684.23 | $1688.28 | $1541.03 | |
| Total operating expenses | $1718.29 | $1684.23 | $1481.94 | $1541.03 |
| Operating income | $1379.33 | $1487.85 | $932.99 | |
| Income from continuing operations | ||||
| EBIT | $1403.96 | $1507.14 | $953.67 | |
| Income tax expense | $213.18 | $222.13 | $277.01 | $158.28 |
| Interest expense | -$117.81 | $116.46 | $106.32 | $111.94 |
| Net income | ||||
| Net income | $1056.83 | $1065.38 | $1123.82 | $683.45 |
| Income (for common shares) | $1065.38 | $1123.82 | $683.45 | |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | $281.82 | $632.22 | ||
| Operating activities | ||||
| Depreciation | $85.67 | $84.71 | ||
| Business acquisitions & disposals | $63 | $466.86 | ||
| Stock-based compensation | $9.52 | $15.16 | ||
| Total cash flows from operations | $203.66 | $166.59 | ||
| Investing activities | ||||
| Capital expenditures | -$40.87 | -$44.48 | ||
| Investments | ||||
| Total cash flows from investing | $48.76 | $28.16 | $429.85 | -$726.63 |
| Financing activities | ||||
| Dividends paid | -$212.37 | -$70.21 | -$71.44 | -$284.3 |
| Sale and purchase of stock | -$1 | -$508.91 | ||
| Net borrowings | -$758.5 | $500.69 | ||
| Total cash flows from financing | -$818.45 | -$830.66 | -$80.78 | -$568.06 |
| Effect of exchange rate | -$6.58 | -$2.37 | -$1.57 | -$6.67 |
| Change in cash and equivalents | -$19.1 | -$601.2 | $514.09 | $34.99 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $1065.38 | $1123.82 | $683.45 | |
| Operating activities | ||||
| Depreciation | $307.54 | $290.12 | $279.05 | |
| Business acquisitions & disposals | -$312.86 | -$837.09 | -$320.39 | |
| Stock-based compensation | $30.82 | $31.11 | $25.03 | |
| Total cash flows from operations | $805.72 | $1115.87 | $1104.81 | |
| Investing activities | ||||
| Capital expenditures | -$214.9 | -$164.4 | -$158.49 | |
| Investments | ||||
| Total cash flows from investing | -$726.63 | -$540.92 | -$992.75 | -$481.38 |
| Financing activities | ||||
| Dividends paid | -$284.3 | -$287.55 | -$286.9 | -$284.31 |
| Sale and purchase of stock | -$599.64 | -$21.64 | -$106.28 | |
| Net borrowings | $629.89 | $105 | -$84.7 | |
| Total cash flows from financing | -$568.06 | -$260.26 | -$249.88 | -$506.29 |
| Effect of exchange rate | -$6.67 | -$9.17 | -$0.8 | -$1.32 |
| Change in cash and equivalents | $34.99 | -$4.64 | -$127.57 | $115.82 |
| Market cap | $24.50B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 137.19M |
| Revenue | $8.36B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $1.56B |
| Revenue Q/Q | -7.88% |
| Revenue Y/Y | -1.30% |
| P/E ratio | 15.73 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 2.93 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $11.35 |
|---|---|
| ROA | 13.39% |
| ROE | N/A |
| Debt/Equity | 1.22 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.57 |
| Quick ratio | 1.06 |